by Debi Vinnedge | Dec 31, 2008 | Archive, Fetal & Vaccine Research, News
Reprinted with permission: Commentary by Judie Brown, President and founder of American Life League and Children of God for Life VP Prolife Activities. http://www.all.org/newsroom_judieblog.php?id=2439 Posted: Wednesday December 31, 2008 at 4:02 pm EST by Judie Brown...
by Debi Vinnedge | Dec 30, 2008 | Archive, Fetal & Vaccine Research, News
December 30, 2008 Julie L. Gerberding, Director,Centers for Disease Control and Prevention 1600 Clifton Rd Atlanta, GA 30333 Dear Ms. Gerberding, I am enclosing a copy of the letter sent to Richard Clark, CEO of Merck regarding their recent decision to halt...
by Debi Vinnedge | Dec 30, 2008 | Archive, Fetal & Vaccine Research, News
December 30, 2008 Richard Clark, CEO Merck & Company One Merck Drive P.O. Box 100 Whitehouse Station, NJ 08889-0100 Dear Mr. Clark, I am writing to you regarding your recent decision to discontinue production and sales of your monovalent measles (Attenuvax) and...
by Debi Vinnedge | Feb 1, 2006 | Archive, News, Vaccines
Published in The Angelus Magazine, Feb 2006 2915 Forest Avenue Kansas City, MO 64109 Publisher: Fr John Fullerton Editor Fr. Kenneth Novak Assistant Editor: Mr. James Vogel The Vaccination Question By Timothy P. Collins, MD Letter From The Editor – The Angelus...
by Debi Vinnedge | Apr 12, 2005 | Archive, News, Stem Cell Research
UPDATE 4-131-05: Letter From GE and Response Note: As long time shareholders of General Electric Stock, we are outraged to learn they will pursue embryonic stem cell research. Despite the declining value of the current market price of their stock, we are left with...
